Cargando…
Human umbilical cord mesenchymal stem cells ameliorate skin fibrosis development in a mouse model of bleomycin-induced systemic sclerosis
Mesenchymal stem cell (MSC) infusion has become a novel therapeutic strategy for complex autoimmune diseases; however, few detailed studies have been performed to investigate the benefit and mechanism of MSC treatment on systemic sclerosis (SSc). The present study aimed to evaluate the therapeutic e...
Autores principales: | Yang, Yuan, Zhu, Shuai, Li, Yanhong, Lu, Qian, Zhang, Qiuyi, Su, Linchong, Zhang, Qiuping, Zhao, Yi, Luo, Yubin, Liu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664606/ https://www.ncbi.nlm.nih.gov/pubmed/33199983 http://dx.doi.org/10.3892/etm.2020.9387 |
Ejemplares similares
-
Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis
por: Roh, Jong Seong, et al.
Publicado: (2021) -
Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats
por: Chen, Huanjie, et al.
Publicado: (2023) -
Dual Effects of Hypoxia-Inducible Factors-1 Alpha in Bleomycin-Induced Pulmonary Fibrosis Treated by Human Umbilical Cord Mesenchymal Stem Cells
por: Zhang, Hongpeng, et al.
Publicado: (2021) -
Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Han, Yuanyuan, et al.
Publicado: (2021) -
Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury
por: MIN, FANG, et al.
Publicado: (2015)